Last edition
News about "rusfertide licensing"
Zealand Pharma Signs USD 100 Million Royalty Deal with Royalty Pharma for Rusfertide
Zealand Pharma will receive USD 100 million from Royalty Pharma for its rusfertide economic interests, unlocking value from royalty rights for strategic investments.
Rusfertide Licensing | 13/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members